Skip to main content

Acquired von Willebrand Disease in Monoclonal Gammapathies: Effectiveness of High-Dose Intravenous Gammaglobulin

  • Conference paper
  • 54 Accesses

Zusammenfassung

Acquired von Willebrand disease (AvWD) is a bleeding disorder strikingly similar to congenital von Willebrand disease in terms of clinical manifestations and laboratory findings being characterized by a prolonged bleeding time and low levels of factor VIII von Willebrand factor (FVIII/vWf) complex, but without a family history of a congenital bleeding tendency and absence of abnormal bleeding after hemostatic challenges.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ivy AC, Nelson D, Bucher GNH (1941) The standardization of certain factors in the cutaneous “venostasis” bleeding time technique. J Lab Clin Med 26: 1812

    Google Scholar 

  2. van Genderen PJJ, Vink T, Michiels JJ, van’t Veer MB, Sixma JJ, van Vliet HHDM (1994) Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of the von Willebrand factor to collagen. Blood 84: 3378

    PubMed  Google Scholar 

  3. Ceika J (1982) Enzyme immunoassay for FVIII-related antigen Clin Chem 26: 1812

    Google Scholar 

  4. Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson JA (1975) A method for assaying von Willebrand factor ( Ristocetine cofactor ). Thromb Diath Haemorrh 34: 306

    Google Scholar 

  5. Brown JE, Bosak JO (1986) An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 43: 303

    Article  PubMed  CAS  Google Scholar 

  6. Brosstad F, Kjönniksen I, Rönning B, Stormorken H (1986) Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies. Thromb Haemost 55: 276

    PubMed  CAS  Google Scholar 

  7. Kaspar CK, Aledort LM, Counts RB et al (1975) A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34: 869

    Google Scholar 

  8. van Genderen PJJ, Michiels JJ, Bakker JJ, van’t Veer MB (1994) Effectiveness of high-dose intravenous gammaglobulin therapy in acquired von Willebrand’s disease. Vox Sang 67: 14

    Article  PubMed  Google Scholar 

  9. van Genderen PJJ, Papatsonis DNM, Michiels JJ, Wielenga JJ, Stibbe J, Huikeshoven FJM (1994) High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease. Postgrad Med J 70: 916

    Article  PubMed  Google Scholar 

  10. van Genderen PJJ, Terpstra W, Michiels JJ, Kapteijn L, van Vliet HHDD (1995) High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease. Thromb Haemost 73: 890

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Michiels, J.J. (1998). Acquired von Willebrand Disease in Monoclonal Gammapathies: Effectiveness of High-Dose Intravenous Gammaglobulin. In: Scharrer, I., Schramm, W. (eds) 27. Hämophilie-Symposion Hamburg 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80403-8_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80403-8_50

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62915-3

  • Online ISBN: 978-3-642-80403-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics